Show simple item record

dc.contributor.authorPisu, Maria
dc.contributor.authorCrenshaw, Katie
dc.contributor.authorFunkhouser, Ellen M.
dc.contributor.authorRay, Midge N.
dc.contributor.authorKiefe, Catarina I.
dc.contributor.authorSaag, Kenneth G.
dc.contributor.authorLaCivita, Cynthia L.
dc.contributor.authorAllison, Jeroan J.
dc.date2022-08-11T08:10:33.000
dc.date.accessioned2022-08-23T17:12:35Z
dc.date.available2022-08-23T17:12:35Z
dc.date.issued2010-11-01
dc.date.submitted2012-04-16
dc.identifier.citationEthn Dis. 2010 Autumn;20(4):339-45.
dc.identifier.issn1049-510X (Linking)
dc.identifier.pmid21305819
dc.identifier.urihttp://hdl.handle.net/20.500.14038/46536
dc.description.abstractOBJECTIVE: To determine if medication assistance programs (MAPs) provided by pharmaceutical companies were used differently by African Americans and Whites. RESEARCH DESIGN: A cross-sectional survey was conducted among patients of primary care practices from 2005 to 2007 within the Alabama Nonsteroidal Anti-Inflammatory Drug (NSAID) Patient Safety Study. SETTING: Telephone survey. PARTICIPANTS: Respondents were 568 African American and White patients reporting annual household incomes < $50,000. MAIN OUTCOME MEASURE: Use of MAPs. RESULTS: Of all patients, 12.8% used MAPs, 39.5% were African American, 75.2% were female, 69.1% were aged > 65 years, 79.8% had annual household incomes < $25,000, and 35.5% indicated that their income was inadequate to meet their basic needs. MAPs were used by 11.2% African-Americans and 14.0% Whites. After multivariable adjustment, MAP use was higher among respondents with incomes not adequate to meet basic needs (odds ratio [OR]: 2.19, 95% confidence interval [CI]: 1.17-4.08) but lower among African Americans than Whites (OR: 0.49, 95% CI: 0.25-0.95). Physician characteristics did not independently predict MAP use. CONCLUSIONS: Overall MAP use was low even among the most vulnerable, and especially among African Americans. As currently used, MAPs may contribute to disparities in medication access.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=21305819&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://www.ishib.org/journal/20-4/ethn-20-04-339.pdf
dc.subjectAfrican Americans
dc.subjectAged
dc.subjectAlabama
dc.subjectCross-Sectional Studies
dc.subjectDrug Industry
dc.subjectDrug Prescriptions
dc.subjectEuropean Continental Ancestry Group
dc.subjectFemale
dc.subjectHumans
dc.subjectLogistic Models
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectSocial Welfare
dc.subjectBiostatistics
dc.subjectEpidemiology
dc.subjectHealth Services Research
dc.titleMedication assistance programs: do all in need benefit equally
dc.typeJournal Article
dc.source.journaltitleEthnicity and disease
dc.source.volume20
dc.source.issue4
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/qhs_pp/1003
dc.identifier.contextkey2767206
html.description.abstract<p>OBJECTIVE: To determine if medication assistance programs (MAPs) provided by pharmaceutical companies were used differently by African Americans and Whites.</p> <p>RESEARCH DESIGN: A cross-sectional survey was conducted among patients of primary care practices from 2005 to 2007 within the Alabama Nonsteroidal Anti-Inflammatory Drug (NSAID) Patient Safety Study.</p> <p>SETTING: Telephone survey.</p> <p>PARTICIPANTS: Respondents were 568 African American and White patients reporting annual household incomes < $50,000.</p> <p>MAIN OUTCOME MEASURE: Use of MAPs.</p> <p>RESULTS: Of all patients, 12.8% used MAPs, 39.5% were African American, 75.2% were female, 69.1% were aged > 65 years, 79.8% had annual household incomes < $25,000, and 35.5% indicated that their income was inadequate to meet their basic needs. MAPs were used by 11.2% African-Americans and 14.0% Whites. After multivariable adjustment, MAP use was higher among respondents with incomes not adequate to meet basic needs (odds ratio [OR]: 2.19, 95% confidence interval [CI]: 1.17-4.08) but lower among African Americans than Whites (OR: 0.49, 95% CI: 0.25-0.95). Physician characteristics did not independently predict MAP use.</p> <p>CONCLUSIONS: Overall MAP use was low even among the most vulnerable, and especially among African Americans. As currently used, MAPs may contribute to disparities in medication access.</p>
dc.identifier.submissionpathqhs_pp/1003
dc.contributor.departmentDepartment of Quantitative Health Sciences
dc.source.pages339-45


This item appears in the following Collection(s)

Show simple item record